Nplate (Romiplostim Subcutaneous) - Current Clinical Trials

Nplate Related Clinical Trials

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin [Recruiting]

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy [Recruiting]

Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia [Recruiting]

A Prospective, Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated With Immune (Idiopathic) Thrombocytopenia Purpura (ITP) [Recruiting]

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Recruiting]

Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving Romiplostim [Recruiting]

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) [Recruiting]

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP [Recruiting]

Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects [Recruiting]

Study of Romiplostim Versus Observation for Chemotherapy Induced Thrombocytopenia [Recruiting]

Single Arm, Open-label, Long-term Study of Romiplostim in Thrombocytopenic Pediatric Subjects With ITP. [Not yet recruiting]

Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training [Recruiting]

A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura [Recruiting]

Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia [Recruiting]

A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia [Recruiting]

Prevention of Thrombocytopenia in Glioblastoma Patients [Recruiting]

Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell [Recruiting]

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP) [Recruiting]

TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients. [Recruiting]

Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma [Recruiting]

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP [Recruiting]

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia [Not yet recruiting]